Has Thomas Biggs, MD received payments from drug or device companies?

Yes. Drug and device makers reported $244,180 in general payments to Thomas Biggs, MD across 98 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Biggs, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Biggs, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Biggs, MD

Cardiovascular Disease · Saint Paul, MNNPI 1902889744

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $232,952 of the $244,180 with a category attached, or 95.4%. Acist Medical Systems, Inc. accounts for 97.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $53,559 and has fallen 55.0% since, to $24,109 in 2025. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$244,180in general payments, 2019–2025

Across 98 payments — averaging $2491.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Acist Medical Systems, Inc.$238K
Boston Scientific$3K
Medtronic$3K
Mentor Worldwide LLC$283
AbbVie$96
Penumbra, Inc.$45
plus $34 from 1 others

$1,238in research payments, 2019–2025

Across 1 payment — averaging $1237.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$1K

What the payments were for

Consulting fees$232,95295%
Speaking & faculty fees$7,9503%
Travel & lodging$1,3741%
Food & beverage$1,9041%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Acist Medical Systems, Inc.	65	$237,728
Boston Scientific	5	$3,321
Medtronic	22	$2,673
Mentor Worldwide LLC	2	$283
AbbVie	1	$96
Penumbra, Inc.	1	$45
Regeneron Healthcare Solutions, Inc.	2	$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CVI SYSTEMS$133,158
Contrast Imaging$53,175
HD-IVUS$35,529
EMPOWER CTA$15,675
EKOSONIC$1,800
SYMPLICITY G3$1,729
GENERAL CATHETERS$788
GENERAL GUIDEWIRES$675
MENTOR MemoryGel Resterilizable Gel Sizer$283
ONYX FRONTIER$247
Telescope$158

How this compares

$244,180 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota →

Medicare billing

Part B allowed, 2024

$47,477

Medicare patients

192

Services billed

446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	137	$184,154
XareltoRivaroxaban	43	$64,605
Repatha SureclickEvolocumab	58	$55,609
JardianceEmpagliflozin	15	$14,278
BrilintaTicagrelor	12	$13,042
Metoprolol Succinate	272	$5,014
Rosuvastatin Calcium	175	$2,195
Atorvastatin Calcium	127	$1,861
Lisinopril	133	$1,452
Ranolazine ErRanolazine	11	$1,196
ClopidogrelClopidogrel Bisulfate	104	$1,181
Ezetimibe	51	$1,056
Amlodipine Besylate	102	$860
Losartan Potassium	75	$747
Furosemide	92	$699

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Saint Paul

Pierce VatterottSaint Paul$146K
Spencer KuboSaint Paul$134K
Johannes BrechtkenSaint Paul$100K
Nishtha SodhiSaint Paul$50K
Jeffrey ChambersMinneapolis$3.2M
Srijoy MahapatraRochester$1.2M
Markus MeyerMinneapolis$786K
Robert SchwartzMinneapolis$502K
Robert VantasselMinneapolis$493K
Charanjit RihalRochester$478K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →